|Articles|March 15, 2022

Evidence-Based Oncology

  • August 2022
  • Volume 28
  • Issue 6

Patel et al, Appendix B

Articles in this issue

over 3 years ago

Advancing Cancer Care Equity: Yes, and…

over 3 years ago

Takeda Partnership With Xavier University Seeks Blueprint to Advance Health Equity

over 3 years ago

NPC Weighs in on PBM Inquiry; Radiologist Receives Award; OneOncology Creates Disease Groups

over 3 years ago

Trilaciclib Before Chemotherapy May Prevent Hematological Events—With Savings

over 3 years ago

Shifting Landscape of Care Delivery Is Impacting Value-Based Cancer Care

over 3 years ago

How Advocacy Groups and Patient Data Can Help Drive Health Equity

over 3 years ago

Taking Action to Address Health Equity in Oncology

over 3 years ago

New Enhancing Oncology Model Builds on Knowledge From the OCM

over 3 years ago

OCM Successor Puts Focus on Equity in Cancer Care—With Fewer Dollars for Services

over 3 years ago

Defining Appropriate Quality Performance Metrics for Pharmacies Dispensing Oral Oncology Therapies

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs
Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

View more
Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

View more
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text